VOLITIONRX LTD · In Vitro & In Vivo Diagnostic Substances

VNRX

High riskNext report: Due any day

View price ↗

The short version

A company still losing money with steady sales, with high risk.

Going well

Sales up 40% last year

Watch out for

About 1 month of cash left at its current burn
Owes more than it owns (negative equity)
Losing money, losses are large next to sales

Money moves

No insider buying or selling in the last 30 days

Facts from SEC filings, not a recommendation.

The business over time

Last 12 quarters, from SEC filings

Sales, Jun '26

$399K-2.0% vs a year earlier

Sep '23Tap a barJun '26

Last 12 months: $2.5M, up 86% from the 12 months before.

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

0/4Weak

MissDebt under half of equityNot relying on borrowed money.Owes more than it owns
MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.Losses many times its sales
MissProfitable every yearSteady profits, not one good year.0 of 10 years
MissFree cash flow positiveBrings in more cash than it spends to run and grow.-$19.8M

Revenue: $1.7M; +40.0% vs prior year
5-year growth: +164.1%/yr; revenue, per year
Total debt: $6.7M
Current ratio: 0.17x; short-term assets / bills due

From annual reports filed with the SEC. Not in this company's SEC data, so not scored: return on equity 15%+, share count not growing, gross margin 40%+. A checklist is a starting point for research, not a verdict.

Latest quarter

Quarter ended Jun 30, 2026

Reported Aug 13

Revenue: $399K; -2.0% YoY
EPS: -$0.85; vs -$18.30
Op. margin: -1042.5%; +506.1 pts
Free cash flow: -$5.2M
Share count: +2575.4%; vs a year ago

Insider rating

Last 90 days

No open-market insider buys or sells in the last 90 days.

Weekly insider trend

No trades to chart yet.

Filing buzz

Last 7 days vs normal

40/ 100

This week: 1
Normal week: 1.4
vs normal: 0.7x

SEC filings of any kind. 50 means a normal week.

Institutional ownership

Steady

The share count changed with a stock split this quarter, so the change in holdings isn't comparable until next quarter.

Shares held by institutions1.9M

Sep '24Jun '26

Safety check

From SEC filings

Share count growthYearly rate, last 3 years

+51.5%

Cash runwayAt last year's cash burn

2 months

Debt to equityLatest balance sheet: debt compared with what owners have

Owes more than it owns

Shares outstandingLatest reported

14M

Why high risk

Losing money, losses are large next to sales
About 2 months of cash left at its current burn
Share count growing 51.5% a year (dilution)
Owes more than it owns (negative equity)
Bills due within a year exceed short-term assets
12 offering filings in 6 months (may sell new shares)
Exchange listing notice (a delisting warning or a move to another exchange)

Earnings reports

Last 12

Next reportDue any dayEstimated from the same quarter last year

Results filedAug 13
Results filedMay 14
Results filedMar 31
Results filedNov 13, 2025
Results filedOct 14, 2025

Flags and big holders

Offerings 6 months, flags 12 months, holders 90 days

Insider trades

Open-market buys and sells, last 90 days

No open-market buys or sells in 90 days. Grants and option exercises are left out.

"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.

Latest filings

Straight from SEC EDGAR

Major agreementOct 27 · Form 8-K ↗

Stock awardAnn-louise BatchelorGroup Chief Marketing Officer

12,000 shares

+76% of holdings
Now owns 27,786 shares
Filed NaN days after trade

Oct 21Form 4 ↗

Shares withheld for taxesGaetan MichelChief Operating Officer

608 shares at $0.25 · $154

-5% of holdings
Now owns 12,232 shares
Filed NaN days after trade

Sep 28Form 4 ↗

Shares withheld for taxesGael ForterreChief Commercial Officer

284 shares at $0.25 · $72

-2% of holdings
Now owns 16,284 shares
Filed NaN days after trade

Sep 28Form 4 ↗

Unregistered share saleSep 25 · Form 8-K ↗5%+ holder update (active)Sep 16 · Form SCHEDULE 13D/A ↗Unregistered share saleSep 15 · Form 8-K ↗Other company newsSep 14 · Form 8-K ↗Shelf offering registration (amended)Sep 9 · Form S-3/A ↗EFFECTSep 9 · Form EFFECT ↗Shelf offering registration (amended)Sep 8 · Form S-3/A ↗New 5%+ holder (active)Sep 4 · Form SCHEDULE 13D ↗Unregistered share saleSep 2 · Form 8-K ↗Major agreementSep 2 · Form 8-K ↗Shelf offering registrationAug 28 · Form S-3 ↗

Source: SEC EDGAR filings. For informational purposes. Not investment advice.

Report a problem with this page